New Data for A Treatment Option in Non-Metastatic CRPC

Program Launch: February 26, 2021                                                             Program Expiration: August 26, 2021



Program Learning Objectives:

  • Provide an overview on nmCRPC, the initial phase of advanced prostate cancer
  • Review the efficacy for a nmCRPC treatment option including new overall survival data
  • View updated safety data from the final analysis for a treatment in nmCRPC
  • Learn about other clinical considerations when prescribing a treatment option in nmCRPC
  • Review key data and clinical considerations for a nmCRPC treatment option

 

Speakers: